Premium
Dopamine activates Nrf2‐regulated neuroprotective pathways in astrocytes and meningeal cells
Author(s) -
Shih Andy Y.,
Erb Heidi,
Murphy Timothy H.
Publication year - 2007
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2006.04345.x
Subject(s) - dopamine , neuroprotection , in vivo , oxidative stress , monoamine neurotransmitter , biology , neurodegeneration , pharmacology , tyrosine hydroxylase , microbiology and biotechnology , keap1 , endogeny , chemistry , neuroscience , transcription factor , serotonin , endocrinology , medicine , biochemistry , gene , receptor , disease
The transcription factor Nrf2 controls inducible expression of multiple antioxidant/detoxification genes. We previously found that Nrf2 ‐/‐ mice have increased sensitivity to in vivo mitochondrial stress and ischemia. Although Nrf2 regulated these forms of neuronal toxicity, it was unclear which injury‐triggered signal(s) led to Nrf2 activation in vivo . In this study, we use primary cultures to test the hypothesis that excessive dopamine release can act as an endogenous Nrf2‐inducing signal. We cultured two cell types that show increased Nrf2 activity during ischemia in vivo , astrocytes and meningeal cells. Cultures were infected with an adenovirus reporter of Nrf2 transcriptional activity. Dopamine‐induced Nrf2 activity in both cell types by generating oxidative stressors, H 2 O 2 and dopamine‐quinones. Nrf2 activation in meningeal cells was significantly higher than astrocytes. The effect of dopamine was blocked by antioxidants, and by over‐expression of either dominant‐negative Nrf2 or Keap1. Nrf2 induction was specific to oxidative stress caused by catecholaminergic neurotransmitters as epinephrine also induced Nrf2, but the monoamine serotonin had no significant effect. These in vitro results suggest Nrf2 activity in astrocytes and meningeal cells link the neurotoxic actions of dopamine to neuroprotective pathways that may potentially modulate ischemic injury and neurodegeneration.